Mapping immune responses to the Helicobacter pylori germ by tagging the antibodies produced in the body can shed light on how stomach cancers develop, EU-funded scientists have found.
EU-funded scientists working on the HELICOMARK project have found ways to assess stomach cancer risk in blood samples using the body’s immune response as a tool.
Further details: How the body fights infection can provide clues to stomach cancer risk